SLC6A3 and Parkinson disease: Notably, lower dopamine transporter activity in the putamen evaluated by 18F-FP-CIT-PET in de-novo PD patients has been described as significant predictor of LID.13 Our results indicate that dopamine deficits in the contralateral putamen in de-novo PD patients is an independent predictor of a shorter time to levodopa initiation.